DIN 02532190 — AURO-SUNITINIB 12.5 MG
AURO-SUNITINIB is a capsule of Sunitinib marketed by AURO PHARMA INC. The full Sunitinib monograph covers indications, dosing, interactions and counselling for every strength and manufacturer.
- DIN
- 02532190
- Brand name
- AURO-SUNITINIB
- Active ingredient
- Sunitinib
- Strength
- 12.5 MG
- Dosage form
- CAPSULE
- Route
- ORAL
- Manufacturer
- AURO PHARMA INC
- Health Canada status
- MARKETED
- Drug class
- Tyrosine kinase inhibitor (antineoplastic agent)
Product data from the Health Canada Drug Product Database, synced . Verify the live status at Health Canada.
Other Sunitinib products
| DIN | Brand | Strength | Form | Manufacturer | Status |
|---|---|---|---|---|---|
| 02532204 | AURO-SUNITINIB | 25 MG | CAPSULE | AURO PHARMA INC | MARKETED |
| 02532220 | AURO-SUNITINIB | 50 MG | CAPSULE | AURO PHARMA INC | MARKETED |
| 02552892 | NAT-SUNITINIB | 12.5 MG | CAPSULE | NATCO PHARMA (CANADA) INC | MARKETED |
| 02552906 | NAT-SUNITINIB | 25 MG | CAPSULE | NATCO PHARMA (CANADA) INC | MARKETED |
| 02539284 | NAT-SUNITINIB | 50 MG | CAPSULE | NATCO PHARMA (CANADA) INC | MARKETED |
| 02532840 | SANDOZ SUNITINIB | 12.5 MG | CAPSULE | SANDOZ CANADA INCORPORATED | MARKETED |
| 02532867 | SANDOZ SUNITINIB | 25 MG | CAPSULE | SANDOZ CANADA INCORPORATED | MARKETED |
| 02532883 | SANDOZ SUNITINIB | 50 MG | CAPSULE | SANDOZ CANADA INCORPORATED | MARKETED |
| 02280795 | SUTENT | 12.5 MG | CAPSULE | PFIZER CANADA ULC | MARKETED |
| 02280809 | SUTENT | 25 MG | CAPSULE | PFIZER CANADA ULC | MARKETED |
| 02280817 | SUTENT | 50 MG | CAPSULE | PFIZER CANADA ULC | MARKETED |
| 02524058 | TARO-SUNITINIB | 12.5 MG | CAPSULE | TARO PHARMACEUTICALS INC | MARKETED |
| 02524066 | TARO-SUNITINIB | 25 MG | CAPSULE | TARO PHARMACEUTICALS INC | MARKETED |
| 02524082 | TARO-SUNITINIB | 50 MG | CAPSULE | TARO PHARMACEUTICALS INC | MARKETED |
| 02526204 | TEVA-SUNITINIB | 12.5 MG | CAPSULE | TEVA CANADA LIMITED | MARKETED |
| 02526212 | TEVA-SUNITINIB | 25 MG | CAPSULE | TEVA CANADA LIMITED | MARKETED |
| 02526220 | TEVA-SUNITINIB | 50 MG | CAPSULE | TEVA CANADA LIMITED | MARKETED |